The Middle East and Africa Intrauterine devices (IUD’S) Market was worth $ 238 million in 2017 and estimated to reach $ 300 million by the end of 2022 with a growing potential of 4.715 %.
- Advertising -
The Middle East and Africa Intrauterine devices (IUD’S) Market was worth $ 238 million in 2016 and estimated to reach $ 300 million by the end of 2021 with a growing potential of 4.715 %.
The intrauterine device (IUD) is most used for reversible family planning method across the world. The earlier IUDs made up of inert plastic materials have largely been archaic in modern practice by products which release levonorgestrel or copper, modifications which significantly enhance high efficacy.
The intrauterine contraceptive device is a safe, effective and convenient contraceptive method.
- Advertising -
The use of IUDs has been limited in less developed countries due to increase in menstrual blood loss which has been a significant issue. So, the most population has been preferred to use the levonorgestrel releasing IUD (LNg IUD) which is highly effective, long-lasting and reduces the blood loss during menstruation in less developed countries.
Access report at: www.marketdataforecast.com/market-…ices-market-1097/
Technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), direct health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies are driving the growth of the market in Middle East and Africa. The factors that are hampering the growth of the market are issues of Infertility, Side effects, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.
The Middle East and Africa intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device.
Access sample report: www.marketdataforecast.com/market-…97/request-sample
Major players influencing the Middle East and Africa intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer AG, Teva Pharmaceutical, Pfizer, Mylan laboratories, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: